---

November 10, 2020

PredictMedix Is Partnering With McGill Researchers for Clinical Research

TORONTO, ON / ACCESSWIRE / November 10, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce that the company is partnering with the research group led by Dr. Samira Rahimi for clinical…

Read full release →

October 27, 2020

PredictMedix Provides Corporate Update

TORONTO, ON / ACCESSWIRE / October 27, 2020 / PredictMedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities in relation to its infectious disease screening technology…

Read full release →

October 16, 2020

Accenture: Health Innovation: A Cure for COVID-19 Disruptions

Bets on a better future A select group of health systems and hospitals are differentiating themselves from their peers, investing in the innovations they need to navigate the long-term uncertainties imposed by COVID-19. These organizations…

Read full release →

October 02, 2020

PredictMedix Partners With Versus Systems To Bring Rewards Program To Promote Patient Trials

PredictMedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive to share details the company has partnered up with Versus Systems to integrate Versus’ proprietary rewards platform with its proprietary remote patient…

Read full release →

October 01, 2020

PredictMedix Partners With Versus Systems to Develop Tools for Clinical Trials

TORONTO, ON / ACCESSWIRE / October 1, 2020 / PredictMedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“PredictMedix” or the “Company”) is pleased to announce that the company is partnering with Versus Systems, Inc. (“Versus”) (CSE:VS) (CSE:VS.CN) (OTCQB:VRSSF) (FRANKFURT:BMVA) to bring tools for clinical…

Read full release →